N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I [S]

  • Kevin S. Thorneloe
  • , Anthony C. Sulpizio
  • , Zuojun Lin
  • , David J. Figueroa
  • , Angela K. Clouse
  • , Gerald P. McCafferty
  • , Tim P. Chendrimada
  • , Erin S.R. Lashinger
  • , Earl Gordon
  • , Louise Evans
  • , Blake A. Misajet
  • , Douglas J. DeMarini
  • , Josephine H. Nation
  • , Linda N. Casillas
  • , Robert W. Marquis
  • , Bartholomew J. Votta
  • , Steven A. Sheardown
  • , Xiaoping Xu
  • , David P. Brooks
  • , Nicholas J. Laping
    • Timothy D. Westfall

Research output: Contribution to journal › Article › peer-review

365 Scopus citations

Fingerprint

Dive into the research topics of 'N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I [S]'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science